应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AXSM Axsome Therapeutics, Inc.
盘后交易 04-26 16:52:32 EDT
71.71
+0.19
+0.27%
盘后
72.00
+0.29
+0.40%
16:44 EDT
最高
72.43
最低
69.70
成交量
27.20万
今开
70.97
昨收
71.52
日振幅
3.82%
总市值
33.97亿
流通市值
25.01亿
总股本
4,737万
成交额
1,945万
换手率
0.78%
流通股本
3,488万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Axsome Therapeutics, Inc.盘中异动 快速跳水5.01%
自选股智能写手 · 04-19
Axsome Therapeutics, Inc.盘中异动 快速跳水5.01%
坎托菲茨杰拉德公司:重申Axsome Therapeutics(AXSM.US)评级,由增持调整至增持评级, 目标价107.00美元。
智通财经 · 04-10
坎托菲茨杰拉德公司:重申Axsome Therapeutics(AXSM.US)评级,由增持调整至增持评级, 目标价107.00美元。
Axsome Therapeutics, Inc.盘中异动 快速拉升5.05%
自选股智能写手 · 03-19
Axsome Therapeutics, Inc.盘中异动 快速拉升5.05%
美国研究综述-美国大厦、莱纳尔、耐克
Reuters · 03-19
美国研究综述-美国大厦、莱纳尔、耐克
美国研究综述-中心空间、荷兰兄弟、签证
Reuters · 01-16
美国研究综述-中心空间、荷兰兄弟、签证
加载更多
公司概况
公司名称:
Axsome Therapeutics, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Axsome Therapeutics, Inc.成立于2012年1月。该公司是一家临床阶段的生物制药企业,开发新的治疗疼痛和其他中枢神经系统或中枢神经系统,疾病管理。通过专注于这一治疗领域,他们正在解决显著和不断增长的市场,其中目前的治疗选择是有限或不充分的。他们的目标是成为一个完全集成的生物制药公司开发和商业化的拓展提供给医护人员的治疗方案,提高生活疼痛和其他中枢神经系统疾病患者的生命分化疗法。
发行价格:
--
{"stockData":{"symbol":"AXSM","market":"US","secType":"STK","nameCN":"Axsome Therapeutics, Inc.","latestPrice":71.71,"timestamp":1714161600000,"preClose":71.52,"halted":0,"volume":272004,"hourTrading":{"tag":"盘后","latestPrice":72,"preClose":71.71,"latestTime":"16:44 EDT","volume":7269,"amount":521262.02531999996,"timestamp":1714164265971},"delay":0,"floatShares":34877322,"shares":47374375,"eps":-5.269999,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.19,"latestTime":"04-26 16:52:32 EDT","open":70.97,"high":72.43,"low":69.7,"amount":19446795.41808,"amplitude":0.038171,"askPrice":73.9,"askSize":60,"bidPrice":64.93,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-5.269999,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714176000000},"adr":0,"listingDate":1447909200000,"adjPreClose":71.52,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":72,"preClose":71.52,"latestTime":"08:00 EDT","volume":25,"amount":1800,"timestamp":1714132800369},"postHourTrading":{"tag":"盘后","latestPrice":72,"preClose":71.71,"latestTime":"16:44 EDT","volume":7269,"amount":521262.02531999996,"timestamp":1714164265971},"volumeRatio":0.434666},"requestUrl":"/m/hq/s/AXSM","defaultTab":"news","newsList":[{"id":"2428468665","title":"Axsome Therapeutics, Inc.盘中异动 快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428468665","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428468665?lang=zh_cn&edition=full","pubTime":"2024-04-19 02:45","pubTimestamp":1713465906,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日02时45分,Axsome Therapeutics, Inc.股票出现异动,股价急速下挫5.01%。Axsome Therapeutics, Inc.股票所在的生物技术行业中,整体跌幅为0.60%。其相关个股中,Artelo Biosciences Inc C/Wts 20/06/2024 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cingulate Inc C/Wts 10/12/2026 涨幅较大,Bio-Path Holdings, Inc.、Benitec Biopharma Inc.、Soligenix, Inc.较为活跃,换手率分别为10640.66%、112.15%、50.63%,振幅较大的相关个股有Bio-Path Holdings, Inc.、Artelo Biosciences Inc C/Wts 20/06/2024 、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ,振幅分别为126.85%、75.31%、73.93%。Axsome Therapeutics, Inc.公司简介:Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190245067a53d1b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190245067a53d1b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426497473","title":"坎托菲茨杰拉德公司:重申Axsome Therapeutics(AXSM.US)评级,由增持调整至增持评级, 目标价107.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426497473","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426497473?lang=zh_cn&edition=full","pubTime":"2024-04-10 21:45","pubTimestamp":1712756738,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司:重申Axsome Therapeutics(AXSM.US)评级,由增持调整至增持评级, 目标价107.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102145428761799a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102145428761799a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420752182","title":"Axsome Therapeutics, Inc.盘中异动 快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420752182","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420752182?lang=zh_cn&edition=full","pubTime":"2024-03-19 22:43","pubTimestamp":1710859381,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日22时43分,Axsome Therapeutics, Inc.股票出现异动,股价急速拉升5.05%。Axsome Therapeutics, Inc.股票所在的生物技术行业中,整体涨幅为0.17%。其相关个股中,Fusion Pharmaceuticals Inc.、Moolec Science Sa C/Wts 、知临集团涨幅较大,Enveric Biosciences, Inc.、Hoth Therapeutics, Inc.、Clearmind Medicine Inc.较为活跃,换手率分别为800.08%、394.76%、135.76%,振幅较大的相关个股有Enveric Biosciences, Inc.、知临集团、Tracon Pharmaceuticals, Inc.,振幅分别为50.91%、49.87%、47.94%。Axsome Therapeutics, Inc.公司简介:Axsome Therapeutics Inc是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192243017a4db691&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192243017a4db691&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420255290","title":"美国研究综述-美国大厦、莱纳尔、耐克","url":"https://stock-news.laohu8.com/highlight/detail?id=2420255290","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420255290?lang=zh_cn&edition=full","pubTime":"2024-03-19 15:17","pubTimestamp":1710832652,"startTime":"0","endTime":"0","summary":" 路透社3月19日 - 华尔街证券分析师周二调整了对美国塔、莱纳尔和耐克等几家美国上市公司的评级和目标价。* 耐克公司 :Wedbush将目标价从131美元下调至115美元 * Zoom Video Communications :杰富瑞给予该公司 \"持有 \"评级,目标价为70美元 以下是路透社周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2403880684","title":"美国研究综述-中心空间、荷兰兄弟、签证","url":"https://stock-news.laohu8.com/highlight/detail?id=2403880684","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2403880684?lang=zh_cn&edition=full","pubTime":"2024-01-16 15:12","pubTimestamp":1705389140,"startTime":"0","endTime":"0","summary":"* 荷兰兄弟公司 :Stifel将其评级从 \"持有 \"上调至 \"买入\"。* Visa Inc :杰富瑞将目标价从 300 美元上调至 305 美元 * 富国银行 :杰富瑞将目标价从 54 美元下调至 52 美元 以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.axsome.com","stockEarnings":[{"period":"1week","weight":0.0883},{"period":"1month","weight":-0.0678},{"period":"3month","weight":-0.2039},{"period":"6month","weight":0.1521},{"period":"1year","weight":0.0201},{"period":"ytd","weight":-0.1014}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Axsome Therapeutics, Inc.成立于2012年1月。该公司是一家临床阶段的生物制药企业,开发新的治疗疼痛和其他中枢神经系统或中枢神经系统,疾病管理。通过专注于这一治疗领域,他们正在解决显著和不断增长的市场,其中目前的治疗选择是有限或不充分的。他们的目标是成为一个完全集成的生物制药公司开发和商业化的拓展提供给医护人员的治疗方案,提高生活疼痛和其他中枢神经系统疾病患者的生命分化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.061264},{"month":2,"riseRate":0.111111,"avgChangeRate":-0.054934},{"month":3,"riseRate":0.333333,"avgChangeRate":0.073863},{"month":4,"riseRate":0.777778,"avgChangeRate":0.169175},{"month":5,"riseRate":0.375,"avgChangeRate":-0.057757},{"month":6,"riseRate":0.625,"avgChangeRate":0.143979},{"month":7,"riseRate":0.5,"avgChangeRate":-0.044552},{"month":8,"riseRate":0.5,"avgChangeRate":0.039182},{"month":9,"riseRate":0.375,"avgChangeRate":-0.026043},{"month":10,"riseRate":0.5,"avgChangeRate":0.002414},{"month":11,"riseRate":0.625,"avgChangeRate":0.164861},{"month":12,"riseRate":0.777778,"avgChangeRate":0.225168}],"exchange":"NASDAQ","name":"Axsome Therapeutics, Inc.","nameEN":"Axsome Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Axsome Therapeutics, Inc.(AXSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Axsome Therapeutics, Inc.(AXSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Axsome Therapeutics, Inc.,AXSM,Axsome Therapeutics, Inc.股票,Axsome Therapeutics, Inc.股票老虎,Axsome Therapeutics, Inc.股票老虎国际,Axsome Therapeutics, Inc.行情,Axsome Therapeutics, Inc.股票行情,Axsome Therapeutics, Inc.股价,Axsome Therapeutics, Inc.股市,Axsome Therapeutics, Inc.股票价格,Axsome Therapeutics, Inc.股票交易,Axsome Therapeutics, Inc.股票购买,Axsome Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Axsome Therapeutics, Inc.(AXSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Axsome Therapeutics, Inc.(AXSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}